PharmAbcine Inc
KOSDAQ:208340
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PharmAbcine Inc
KOSDAQ:208340
|
KR |
|
Gigcapital5 Inc
NASDAQ:QTI
|
US |
|
B
|
Binh Dinh Book and Equipment JSC
VN:BDB
|
VN |
|
R
|
Reinhold Europe AB
WSE:RHD
|
SE |
|
C
|
China New City Commercial Development Ltd
HKEX:1321
|
CN |
|
N
|
Nusantara Infrastructure Tbk PT
IDX:META
|
ID |
|
Kyokuto Co Ltd
TSE:2300
|
JP |
|
S
|
Semapa Sociedade de Investimento e Gestao SGPS SA
ELI:SEM
|
PT |
|
P
|
Phol Dhanya PCL
SET:PHOL
|
TH |
|
D
|
Dn Agrar Group SA
XBSE:DN
|
RO |
|
Oncology Pharma Inc
OTC:ONPH
|
US |
|
Imunon Inc
NASDAQ:IMNN
|
US |
|
A
|
Ashmore Group PLC
F:A1B
|
UK |
|
U
|
UOB Kay Hian Securities Thailand PCL
SET:UOBKH
|
TH |
|
P
|
Principal Capital PCL
SET:PRINC
|
TH |
Shareholder Yield
Current shareholder yield for PharmAbcine Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
PharmAbcine Inc
| Average Annual Return | -43.94% |
| Standard Deviation of Annual Returns | 24.08% |
| Max Drawdown | -92% |
| Market Capitalization | 9.2B KRW |
| Shares Outstanding | 3 164 024 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
PharmAbcine Inc's latest stock split occurred on Aug 19, 2021
The company executed a 5-for-4 stock split, meaning that for every 4 shares held, investors received 5 new shares.
Before the split, PharmAbcine Inc traded at 13350.0002 per share. Afterward, the share price was about 10500.
The adjusted shares began trading on Aug 19, 2021. This was stock split number 3 in PharmAbcine Inc's history, following the previous one in Jul 6, 2021.
